Drug Type Biosimilar, Monoclonal antibody |
Synonyms- |
Target |
Mechanism IL-5 inhibitors(Interleukin-5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | US | 08 May 2024 |